Viewing Study NCT00454805


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2025-12-31 @ 5:59 PM
Study NCT ID: NCT00454805
Status: COMPLETED
Last Update Posted: 2016-08-03
First Post: 2007-03-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
Sponsor: AstraZeneca
Organization: